Exploring Enhanced Cell-Based Therapy for Ischemic Heart Disease and Heart Failure
1Department of Pathology, Cardiology Division, University of Pisa, C/o Ospedale di Cisanello, Via Paradisa 2, 56124 Pisa, Italy.
Journal of Clinical Medicine
|July 9, 2022
Insights
Ischemic heart disease (IHD) and heart failure (HF) are leading global causes of death. Further research is crucial for developing effective treatments and improving patient outcomes in cardiovascular medicine.
Area of Science:
- Cardiology
- Biomedical Research
- Public Health
Background:
- Ischemic heart disease (IHD) and heart failure (HF) represent significant global health challenges, contributing substantially to mortality rates worldwide.
- Understanding the underlying pathophysiology and epidemiological trends of IHD and HF is essential for effective public health strategies and clinical interventions.
Discussion:
- The complex interplay of genetic, environmental, and lifestyle factors contributes to the high prevalence of IHD and HF.
- Current therapeutic strategies for IHD and HF have limitations, necessitating exploration of novel treatment modalities and preventative measures.
Key Insights:
- Identifying specific risk factors and vulnerable populations is critical for targeted interventions.
- Advancements in diagnostic tools and personalized medicine hold promise for earlier detection and more effective management of IHD and HF.
Outlook:
- Future research should focus on regenerative medicine, innovative pharmacological approaches, and integrated care models to combat the burden of IHD and HF.
- Global collaboration and data sharing are vital to accelerate progress in cardiovascular disease research and improve patient survival and quality of life.
Abstract:
Ischemic heart disease (IHD) and heart failure (HF) remain the leading causes of death worldwide [...].
More Related Videos
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
25
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25
01:21Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
01:17Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
503
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
503
01:30Cardiomyopathy II: Dilated Cardiomyopathy
20
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
20
01:29Cardiomyopathy V: Interprofessional Care
30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30